Oncocross (온코크로스)
Oncocross (온코크로스)
Claim
Oncocross strives to develop treatments for intractable and rare diseases with their transcriptome data-based AI platforms and drug discovery pipelines. Oncocross’s main proprietary AI platforms are RAPTOR AI™ for drug development, and ONCO-RAPTOR AI™ for the identification of optimal indications of anticancer drugs and companion diagnostic biomarkers.Oncocross strives to develop treatments for intractable and rare diseases with their transcriptome d Show More
Alpha Score
$ 101.41 M
Alpha Score
71.1
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0